AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT06242990 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Y-PATH NI
Description: The Y-PATH NI intervention provides a whole of school approach with student, teacher, parent and guardian components. Student components: Y-PATH resources delivered by physical education teachers (6 lesson plans, resource cards to use as teaching prompts), student handbook. Posters are also displayed in the sports hall/ PE department.~Teacher components: Teachers will receive online and in-person training to deliver the Y-PATH programme. This component also targets all non-specialist PE teachers and includes workshops, information leaflets, development of a physical activity promotion charter and a step challenge.~Parent/guardian components: Information session and leaflets distributed across the intervention period.
Study NCT05292495 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HR17031 injection
Description: HR17031 injection; administered subcutaneously.
Study NCT06376435 — intervention group
Intervention type: DRUG
Intervention: Herombopag Olamine Tablets
Description: Herombopag Olamine；combined rhTPO;combined IL-11
Study NCT04851535 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Jaktinib Hydrochloride Tablets
Description: Jaktinib 100mg Bid
Study NCT06102681 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: intervention group
Description: we will measure, consider and compare patients pain level, quality of life and recovery process. For these aims we will use numeric pain scale, nottingham health profile and postoperative recovery index.
Study NCT05669183 — intervention group
Intervention type: PROCEDURE
Intervention: Veno-arterial extracorporeal membrane oxygenation
Description: Veno-arterial extracorporeal membrane oxygenation (VA ECMO) is mainly used for circulatory support in patients with severe cardiopulmonary failure. VA ECMO drains the blood from the venous system followed pumping the blood back into the arterial vascular compartment after oxygenation. It can be divided into two cannulation strategies for VA ECMO support, namely peripheral VA ECMO and central VA ECMO based on the arterial cannulation site. Peripheral VA ECMO is established via the femoral artery (FA), whereas axillary artery (AX) is an arterial cannulation site in central VA-ECMO.
Study NCT05399836 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Portion size manipulation
Description: The intervention will be administered via changing portion sizes of foods served to participants.
Study NCT04193605 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Mindfulness
Description: The traditional MBSR intervention consists of the following: (1) a series of eight weekly session of 2.5 to 3 hours; (2) a silent retreat during the sixth week; (3) daily home assignments including formal and informal mindfulness practices; and (4) didactic presentations on stress and the consequences of stress. We are culturally tailoring the intervention with the goal of maintain fidelity.
Study NCT04416191 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Limb immobilization
Description: Participants will undergo a 2-week period of leg immobilization
Study NCT06371326 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ZT002 Injection
Description: Participants will receive ZT002 by subcutaneous (SC) injection.
Study NCT06371326 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Participants will receive Placebo by subcutaneous (SC) injection.
Study NCT04955652 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Health Maintenance Topic
Description: Alert
Study NCT04955652 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Health Maintenance Topic
Description: Alert
Study NCT04955652 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Actionable Sidebar Item
Description: Alert
Study NCT04955652 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Actionable Sidebar Item
Description: Alert
Study NCT04955652 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Best Practice Alert
Description: Alert
Study NCT06362928 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: ATC System
Description: The ATC System is designed to mechanically remove emboli and restore blood flow through the pulmonary arteries in patients experiencing acute PE
Study NCT04702308 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Clinical Decision Rule Alerts
Description: The
Study NCT06474273 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Methylprednisolone
Description: IV Methylprednisolone
Study NCT06474273 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Methylprednisolone
Description: IV Methylprednisolone
Study NCT06474273 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Prednisone
Description: Oral prednisone augmentation
Study NCT06474273 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Prednisone
Description: Oral prednisone augmentation
Study NCT05551871 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Simvastatin
Description: the patient will receive Simvastatin for 7 days
Study NCT05551871 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo drug
Description: the patient will receive Placebo drug for 7 days
Study NCT06069115 — intervention group
Intervention type: RADIATION
Intervention: Radiation therapy protocol for Breast cancer
Description: Conformal 3D radiation therapy will be performed 4-12 weeks after surgical treatment of breast cancer on Electa Axesse linear gas pedal with 6 MeV energy in traditional fractionation mode. Different RT schemes will be used depending on the stage of the disease, type of surgical treatment, and morphological variant of the tumor. In organ-preserving surgeries the remaining breast will be irradiated with a single focal dose (FD) of 2 Gy, up to the total focal dose (TFD) of 50 Gy. In the presence of risk factors, irradiation of lymphatic outflow pathways will be performed: axillary, sub/adclavicular and parasternal lymph nodes areas (FD 2 Gy, up to TFD 44-46 Gy). In radical breast resection we'll use irradiation of the anterior chest wall in 2 Gy FD, up to 50 Gy FD, irradiation of lymphatic outflow pathways: axillary, sub/adclavicular and parasternal lymph nodes (2 Gy FD, up to 44-46 Gy FD).
Study NCT06069115 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Spirography and assessment of pulmonary diffusion capacity
Description: Using the Master Screen Body device you will be asked to take two series of breaths through a special tube for 2-3 minutes. Usually the procedure does not cause any discomfort
Study NCT06069115 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Cardiopulmonary stress test
Description: The exercise test is performed on a bicycle ergometer Oxycon Pro. Prior to the test, special sensors for recording the electrocardiogram, a sensor to determine blood saturation, and a cuff to measure blood pressure will be glued on the body. Breathing during the test takes place through a face mask with a built-in gas analyzer sensor. The stress test is conducted up to an individual maximum (according to the age, sex, height and weight of the patient), followed by a recovery period. There is some temporary discomfort associated with performing physical activity. Dyspnea, leg fatigue, and dizziness may occur. Observation continues until full recovery of hemodynamic and gas exchange parameters, in case of appearance of unfavorable symptoms - until their disappearance.
Study NCT06069115 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Computed tomography of the chest organs
Description: CT is a method of examination based on X-rays, but unlike conventional X-rays, it gives the most complete picture of the body structure, with less radiation.~Tomography usually does not cause any unpleasant feelings and is performed in a specialized department.
Study NCT06069115 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: SF-36 Quality of Life Questionnaire
Description: Standard questionnaire for assessment quality of patient's life https://clinmedjournals.org/articles/jmdt/jmdt-2-023-figure-1.pdf
Study NCT06069115 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Demographic and anthropometric measures
Description: Age, sex, height. weight, body mass index (BMI)
Study NCT06069115 — intervention group
Intervention type: OTHER
Intervention: Indicators characterizing the severity of the underlying disease
Description: Severity of underlying disease (mMRC, BODE, SMRT-CO Respiratory Support Need Scale), and comorbidities (cardiovascular disease, diabetes mellitus, chronic obstructive pulmonary disease, chronic kidney disease) Medications taken.
Study NCT05744141 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Relaxation Exercises
Description: Relaxation exercises consist of voluntary, rhythmic and regular stretching and relaxation of large and small muscle groups until the whole body relaxes. For this exercise application, the Relaxation Exercises CD prepared by the Turkish Psychological Association will be used. The CD consists of 30 minutes and relaxation exercises are explained with the sound of a stream accompanied by verbal instructions. This exercise includes rhythmic breathing, muscle relaxation exercises and music (stream sound).
Study NCT05250011 — intervention group
Intervention type: DRUG
Intervention: Dapagliflozin
Description: Dapagliflozin, prescribed as per approved indication and current medical practice. Participants will not receive any experimental disease management intervention or experimental treatment as a consequence of their participation in the study.
Study NCT04251520 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Pharmacogenomics testing
Description: Participants will undergo pharmacogenomics testing and will be asked to provide a one-time buccal scraping. These results will be utilized for clinical treatment decisions.
Study NCT06263608 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: (Cardio)Respiratory polygraphy (NOX T3s)
Description: This home-based device enables the detection of obstructive sleep apnea by calculating the apnea hypopnea index (AHI).
Study NCT06263608 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: Polysomnography
Description: Polysomnography allows both sleep and respiration monitoring during an overnight stay in a dedicated sleep clinic.
Study NCT06263608 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Devices to deliver Continuous Positive Airway Pressure (CPAP), Bilevel Positive Airway Pressure (BiPAP) or Adaptive support ventilation (ASV)
Description: Devices can be used to deliver CPAP, BiPAP, or ASV treatment to open up the airways, making breathing during sleep possible.
Study NCT06263608 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Fitbit smartwatch
Description: The smartwatch enables the semi-continuous monitoring of the heart rhythm via the installed FibriCheck algorithm.
Study NCT04251520 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Pharmacist review
Description: Participants will have their medical information, including patient demographics, problem list, medication list, allergies, and relevant lab work reviewed by a One Point pharmacist. The pharmacist will work with the Palliative Medicine team to make medication related recommendations to improve individual patient care. The pharmacist will call the patient roughly 48 hours following their outpatient consultation or hospital discharge to review the medication list and address any medication-related questions. The pharmacy will send refill reminders to the patients.
Study NCT06482632 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: Discectomy of Omohyoid
Description: Will be removing the Omohyoid during an anterior cervical discectomy and fusion to compare its effect of dysphagia.
Study NCT06482632 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: Control group no discectomy of Omohyoid
Description: Will not be removing the Omohyoid during an anterior cervical discectomy and fusion to compare its effect of dysphagia.
Study NCT05438914 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Repair of the subscapularis
Description: The subscapularis will be repaired using the suture through bone and prosthesis holes surgical technique.
Study NCT05738317 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Adebrelimab Combined With Bevacizumab and Albumin Paclitaxel
Description: Adebrelimab is recommended to be administered with an infusion pump. The infusion pipeline is equipped with a 0.22-micron online filter membrane. Intravenous injection or bolus injection is not allowed. At the end of infusion, flush the infusion tube with sufficient 5% glucose or physiological saline, and do not share the same infusion tube with other drugs. In each treatment cycle, Adebrelimab should be given intravenously first.
Study NCT05289973 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: TruNatomy Files
Description: Newly introduced endodontic file with high flexibility.
Study NCT05289973 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: HyFlex EDM Files
Description: Endodontic files
Study NCT05597111 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: DHA levels of blood and cervical mucus
Description: DHA levels of blood and cervical mucus of the control and the study groups will be measure
Study NCT05938608 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Regimen 1 (Oral primaquine)
Description: Primaquine 15 mg base orally once
Study NCT05938608 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Regimen 2 (IV primaquine phosphate)
Description: Primaquine 7.5 mg base in normal saline 500 mL infused over 30 minutes intravenously
Study NCT05938608 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Regimen 3 (IV carboxyprimaquine)
Description: Carboxyprimaquine 7.93 mg base in normal saline 500 mL infused over 30 minutes intravenously
Study NCT04773301 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Levobupivacaine
Description: Local anaesthetic drug belonging to the amino amide group. It is the S-enantiomer of bupivacaine
Study NCT04773301 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ropivacaine
Description: Local anaesthetic drug belonging to the amino amide group. The name ropivacaine refers to both the racemate and the marketed S-enantiomer.
Study NCT05386030 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: saypha® VOLUME Lidocaine
Description: Crosslinked hyaluronic acid (HA) 23 mg/mL + 0.3% lidocaine hydrochloride.
Study NCT05386030 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: ACTIVE_COMPARATOR
Intervention: Juvéderm® Voluma™ XC
Description: Crosslinked HA 20 mg/mL + 0.3% lidocaine hydrochloride
Study NCT06262802 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Active decompression
Description: Intracystic active negative pressure
Study NCT06262802 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Active decompression
Description: Intracystic active negative pressure
Study NCT04780282 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Scapular Stabilization Group
Description: Participants will apply the 5 exercises given.
Study NCT06508697 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: invasive coronary angiography (ICA) with fractional flow reserve (FFR) pressure measurement
Description: A consecutive series of patients who underwent Coronary computed tomography angiography (CTA) within 90 days before invasive coronary angiography (ICA) with fractional flow reserve (FFR) pressure measurement were candidates for this study at Fujita Health University Hospital, Bantane Hospital, and Nagoya First Red Cross Hospital
Study NCT06404229 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: CardioPulmonary Exercise Testing
Description: CardioPulmonary Exercise Testing using an arm ergometer prior to surgery
Study NCT06423001 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: PostbiotiX Slowing 4 g sachets PostbiotiX Slowing is a food supplement based on Fermented FOS from Lactobacillus paracasei CNCM I-5220.
Description: Each patient will be supplied with the investigational product at Visit 0, PostibiotiX Slowing and at visit 3, based on the outcome of the randomization at V0 (Sequence AB, PostbiotiX Slowing/Placebo; Sequence BA, Placebo/PostbiotiX Slowing).
Study NCT05522543 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Conventional treatment with Passive translatoric intervertebral glides
Description: Patient education (Postural correction, lifting, sitting and sleeping positions) • Hot Pack 10 mins~• PA Glides (Central and Transverse mobilizations) (10 sec each) x5 sets • Core stabilization exercise (Knee to chest, bridges, prone press ups, cat and camel stretches) • Home plan (bridges, knee to chest, cat and camel stretch and prone press ups
Study NCT05522543 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Conventional treatment with manual segmental lumbar traction
Description: Patient education (Postural correction, lifting, sitting and sleeping positions) • Hot Pack 10 mins~• Manual lumbar Traction (L1-L5) for 15-20 sec x5 sets • Lumbar facet gapping (LFG) in side lying (10 sec 3 sets) and Lumbar rotational facet gapping (LRFG) in side lying (10 sec 3 sets) • .Core stability exercises (Knee to chest, bridges, prone press ups, cat and camel stretches) • Home plan
Study NCT03654040 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: arTreg
Description: Eligible participants will receive a single dose of Treg product (arTreg). The target dose is at least 90 x 10\^6 total cells.~Method of receipt: peripheral intravenous (IV) infusion, administered over 20 to 30 minutes.
Study NCT03654040 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: leukapheresis
Description: Leukapheresis will be the method employed to recover peripheral blood mononuclear cells (PBMCs) from the allograft recipient. The recipient will undergo the procedure prior to initiating the cyclophosphamide conditioning regimen.~Procedure on Day -3 (-1 day) prior to Treg product (arTreg) IV infusion.
Study NCT03654040 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: cyclophosphamide
Description: 40 mg/kg administered intravenously (IV) following leukapheresis and between 1 to 3 days prior to Treg product (arTreg) infusion, per institutional standard of care.
Study NCT03654040 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: mesna
Description: Mesna is administered:~* Intravenously to inhibit hemorrhagic cystitis induced by cyclophosphamide, and~* In conjunction with the cyclophosphamide, per institutional practice with CTX.
Study NCT03654040 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: everolimus
Description: EVR is approved for prophylaxis of allograft rejection in adults receiving a liver transplant. Per protocol: Post transplantation, subject will initially receive standard IS with tacrolimus (TAC),plus a mycophenolate product and/or steroids.Subsequently, evaluation for eligibility to be converted to EVR-based IS regimen will occur and, when applicable, proceed. Once the optimal EVR trough level is achieved,TAC dose will be reduced. When target EVR and TAC levels are maintained over two consecutive measurements, ALT liver function test (LFT) is ≤50 U/L, GGT LFT is ≤ the upper limit of normal or ≤ 1.5 times the baseline GGT, subject will be considered successfully converted to EVR-based IS regimen. EVR doses will be administered/monitored/adjusted over time.
Study NCT05871658 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: electroacupuncture
Description: electroacupuncture were inserted into bilateral Zusanli (ST36), Sanyinjiao (SP6), Hegu (LI4) and Quchi (LI11), and Yintang (EX-HN3). Electroacupuncture parameters selected the sparse wave, the frequency was 4 Hz, the stimulation intensity was tolerated by the patient.
Study NCT05871658 — intervention group
Intervention type: BEHAVIORAL
Group type: SHAM_COMPARATOR
Intervention: electroacupuncture
Description: electroacupuncture were inserted into bilateral Zusanli (ST36), Sanyinjiao (SP6), Hegu (LI4) and Quchi (LI11), and Yintang (EX-HN3). Electroacupuncture parameters selected the sparse wave, the frequency was 4 Hz, the stimulation intensity was tolerated by the patient.
Study NCT04842786 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Coconut oil
Description: Coconut oil, Parachute oil composition: 92% lauric (C12) fatty acid, 6% oleic fatty acid, 2% linoleic fatty acid
Study NCT05600465 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Behavioral Activation + Occupational Therapy
Description: In the BA-OT Approach, the PI will use an evidence-based 4-step process (Goal-Plan-Do-Check) to assist the older adults to develop strategies to plan and execute daily health self-management activities. BA-OT teaches older adults with MCC and functional limitations to 1) set achievable and meaningful activity goals, 2) engage in action planning that includes brainstorming strategies to overcome barriers, 3) evaluate the results after performing the activity, and 4) to modify the plan or choose a new goal, then generalize strategies to new problems. By assisting participants to develop daily routines and integrate safe health self-management activities into these routines, occupational therapists are providing strategies that support adaptation in the face of stressful situations.. Goal examples may include adapting and scheduling exercise plans, or exploring assistive devices and strategies for safe and healthy meal preparation.
Study NCT05600465 — intervention group
Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Enhanced Usual Care
Description: Fitbit, 1 hour training, handout on managing chronic conditions